Clinical Trial Update: Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma [NA]

View source ↗

Summary

This clinical trial update analyzes how genetic factors relate to chemotherapy side effects and response rates in patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Washington University School of Medicine | Conditions: Lymphoma, Diffuse Large Cell | NA | Status: COMPLETED